Thomas Patrick Kelly insider trades

Open-market stock purchases and sales by Thomas Patrick Kelly, Chief Financial Officer at Xenon Pharmaceuticals Inc, from SEC Form 4 filings since Oct 2, 2017.

Recent trades

DateStockTradeValue
Oct 15, 2026XENE Xenon Pharmaceuticals IncBought (not open market)—
Oct 15, 2026XENE Xenon Pharmaceuticals IncBought (not open market)—
Sep 30, 2026XENE Xenon Pharmaceuticals IncBought$560K

Companies traded

  • XENE Xenon Pharmaceuticals Inc: 1 buy, last Oct 15, 2026
  • DCPH Deciphera Pharmaceuticals, Inc: 39 sales, last Feb 16, 2024

Get free alerts when Thomas Patrick Kelly files a new trade →